MicroRNA-370 carried by M2 macrophage-derived exosomes alleviates asthma progression through inhibiting the

Chunlu Li1, Chengsi Deng2, Tingting Zhou2

  • 1Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China.

Insights

M2 macrophage-derived exosomes (M2Φ-Exos) alleviate asthma by delivering miR-370, which targets fibroblast growth factor 1 (FGF1). This process inhibits airway smooth muscle cell proliferation and inflammation, offering a potential new asthma treatment.

Area of Science:

  • Immunology
  • Cell Biology
  • Respiratory Medicine

Background:

  • Exosomes play roles in allergic diseases like asthma.
  • Understanding exosome function in asthma progression is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the role of M2 macrophage-derived exosomes (M2Φ-Exos) in asthma.
  • To elucidate the molecular mechanisms by which M2Φ-Exos exert protective effects in asthma.

Main Methods:

  • Ovalbumin (OVA)-induced asthma mouse model.
  • Primary mouse airway smooth muscle cells (ASMCs) treated with platelet-derived growth factor (PDGF-BB).
  • miRNA sequencing, gene silencing, and overexpression techniques.

Main Results:

  • M2Φ-Exos reduced lung fibrosis and inflammation in asthma models.
  • M2Φ-Exos inhibited ASMC proliferation, invasion, and fibrosis-related protein production.
  • M2Φ-Exos delivered miR-370, targeting FGF1 and inactivating the MAPK signaling pathway.

Conclusions:

  • M2Φ-Exos alleviate asthma progression by downregulating FGF1 via miR-370.
  • The mechanism involves the MAPK/STAT1 signaling pathway.
  • M2Φ-Exos represent a potential therapeutic strategy for asthma.

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.4K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
903
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K